(Press-News.org) ROCHESTER, Minn. -- Researchers at Mayo Clinic (http://www.mayoclinic.org/) have found a significant difference in cancer progression and death in chronic lymphocytic leukemia (CLL) patients who had sufficient vitamin D (http://www.mayoclinic.com/health/vitamin-d/NS_patient-vitamind) levels in their blood compared to those who didn't.
VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Tait Shanafelt, are available on the Mayo Clinic News Blog (http://newsblog.mayoclinic.org/2010/11/03/mayo-clinic-finds-insufficient-vitamin-d-levels-in-cll-patients-linked-to-cancer-progression-and-death/).
In the Mayo Clinic study, published online in the journal Blood (http://bloodjournal.hematologylibrary.org/), the researchers found that patients with insufficient levels of vitamin D when their leukemia was diagnosed progressed much faster and were about twice as likely to die as were patients with adequate levels of vitamin D.
They also found solid trends: increasing vitamin D levels across patients matched longer survival times and decreasing levels matched shortening intervals between diagnosis and cancer progression. The association also remained after controlling for other prognostic factors associated with leukemia progression.
The finding is significant in a number of ways. For the first time, it potentially offers patients with this typically slower growing form of leukemia a way to slow progression, says the study's lead author, Tait Shanafelt, M.D., (http://mayoresearch.mayo.edu/staff/shanafelt_td.cfm) a hematologist at Mayo Clinic in Rochester, Minn.
"This finding may be particularly relevant for this kind of leukemia because although we often identify it at an early stage, the standard approach is to wait until symptoms develop before treating patients with chemotherapy," Dr. Shanafelt says. "This watch and wait approach is difficult for patients because they feel there is nothing they can do to help themselves."
"It appears vitamin D levels may be a modifiable risk factor for leukemia progression. It is simple for patients to have their vitamin D levels checked by their physicians with a blood test," he says. "And if they are deficient, vitamin D supplements are widely available and have minimal side effects."
While the researchers have not yet determined if vitamin D replacement in patients with initially low levels will reverse the more rapid progression associated with insufficiency, they are planning a study to explore that hypothesis.
This research adds to the growing body of evidence that vitamin D deficiency is a risk factor for development and/or progression of a number of cancers, the researchers say. Studies have suggested that low blood vitamin D levels may be associated with increased incidence of colorectal, breast and other solid cancers. Other studies have suggested that low vitamin D levels at diagnosis may be associated with poorer outcomes in colorectal, breast, melanoma and lung cancers, as well as lymphoma.
Replacing vitamin D in some patients has proven to be beneficial, the researchers say. For example, they cite a placebo-controlled clinical trial that found women who increased their vitamin D intake reduced their risk of cancer development.
Vitamin D insufficiency, in general, is widespread, Dr. Shanafelt says. "Between one-fourth and one-half of patients seen in routine clinical practice have vitamin D levels below the optimal range, and it is estimated that up to 1 billion people worldwide have vitamin D insufficiency," he says.
Vitamin D is obtained from skin exposure to sunlight, from certain foods (fatty fish and eggs) and from supplements.
In this study, the research team, including physicians at the University of Iowa (http://www.uihealthcare.com/), enrolled 390 CLL patients into a prospective, observational study. They tested the blood of these newly diagnosed patients for plasma concentration of 25-hydroxyl-vitamin D and found that 30 percent of these CLL patients were considered to have insufficient vitamin D levels, which is classified as a level less than 25 nanograms per milliliter.
After a median follow-up of three years, CLL patients deficient in vitamin D were 66 percent more likely to progress and require chemotherapy; deficient patients also had a two-fold increased risk of death.
To confirm these findings, they then studied a different group of 153 untreated CLL patients who had been followed for an average of 10 years. The researchers found that about 40 percent of these 153 CLL patients were vitamin D deficient at the time of their diagnosis. Patients with vitamin D deficiency were again significantly more likely to have had their leukemia progress and to have died, Dr. Shanafelt says.
"This tells us that vitamin D insufficiency may be the first potentially modifiable risk factor associated with prognosis in newly diagnosed CLL," he says.
INFORMATION:
The study was funded by the National Institutes of Health (http://www.nih.gov/), Gabrielle's Angel Foundation for Cancer Research (http://www.gabriellesangels.org/), the Henry J. Predolin Foundation, Vysis, Inc., and the Mayo Hematologic Malignancies Fund. The authors declare no conflicts of interest.
About Mayo Clinic
Mayo Clinic is a non-profit worldwide leader in medical care, research, and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.
LA JOLLA, CA, November 3, 2010 – For Immediate Release – As babies grow, their brain cells develop from a pool of stem cells—some stem cells continuously divide, replenishing the pool, whereas others morph into mature functioning nerve cells. Now researchers at The Scripps Research Institute have shown that as the newly formed nerve cells start firing electrical signals, this activity slows down stem cell division, emptying out the stem cell pool in favor of nerve cell formation.
The study, published in the November 4 issue of the journal Neuron, shows that brain activity ...
Telomerase is an enzyme that maintains the DNA at the ends of our chromosomes, known as telomeres. In the absence of telomerase activity, every time our cells divide, our telomeres get shorter. This is part of the natural aging process, as most cells in the human body do not have much active telomerase. Eventually, these DNA-containing telomeres, which act as protective caps at the ends of chromosomes, become so short that the cells die.
But in some cells, such as cancer cells, telomerase, which is composed of RNA and proteins, is highly active and adds telomere DNA, ...
By applying electrical current to the brain, researchers reporting online on November 4 in Current Biology, a Cell Press publication, have shown that they could enhance a person's mathematical performance for up to 6 months without influencing their other cognitive functions. The findings may lead to treatments for the estimated 20 percent of the population with moderate to severe numerical disabilities (for example, dyscalculia) and for those who lose their skill with numbers as a result of stroke or degenerative disease, according to the researchers.
"I am certainly ...
Researchers have experimentally shown that some species of reef fish will enact punishment on the parasitic saber-tooth blennies that stealthily attack them from behind and take a bite, even though their behavior offers no immediate gain. The study, published online on November 4 in Current Biology, a Cell Press publication, shows that punishment ultimately serves all members of the reef fish species well.
In future attacks, blennies are more likely to go after "free-riding" individuals that don't take the time or expend the energy to punish their enemies, the researchers ...
The adult human skeleton undergoes constant remodeling, with new bone forming at sites that have been broken down by a precise process called resorption. During remodeling, skeletal stem cells are recruited to resorption sites and directed to differentiate into bone-forming cells. Osteoporosis, a condition characterized by weak and fragile bones, develops when there is an imbalance in the remodeling process and more bone is lost than replaced. Now, new research published by Cell Press in the November issue of the journal Cell Stem Cell uncovers a mechanism that may guide ...
Although human and chimpanzee immune systems have many identical components, this is not the case for the family of killer cell immunoglobulin-like receptors (KIR) controlling white blood cells known as natural killer (NK) cells. Published in the open-access journal PloS Genetics on November 4, a paper by Stanford University researchers describes qualitative KIR differences, acquired after humans and chimpanzees separated 6 million years ago and mainly a consequence of innovation in the human line. These differences open up an exciting avenue for explaining the differential ...
A new study published today shows a genetic 'battle of the sexes' could be much harder to resolve and even more important to evolution than previously thought.
This battle, observed across many species and known as intralocus sexual conflict, happens when the genes for a trait which is good for the breeding success of one sex are bad for the other – sparking an 'evolutionary tug-o-war' between the sexes.
It has previously been thought these issues were only resolved when the trait in question evolves to become sex-specific in its development – meaning the trait only ...
ASDs include a range of neurodevelopmental conditions that are being diagnosed at an increasing rate. The Center for Disease Control and Prevention estimates that ASD currently affects 1 in 110 people. The prevalence of schizophrenia, with a diagnostic rate of 1 in 100 to 1 in 20, is similar. ASD and schizophrenia affect males more often than females, and both are thought to have a strong and overlapping genetic component. "The genetic overlap between ASD and schizophrenia, both of which have a high heritability, has been the focus of several recent studies; however, no ...
A research team led by Teh-hui Kao, professor of biochemistry and molecular biology at Penn State University, in collaboration with a team lead by Professor Seiji Takayama at the Nara Institute of Science and Technology in Japan, has discovered a large suite of genes in the petunia plant that acts to prevent it from breeding with itself or with its close relatives, and to promote breeding with unrelated individuals. In much the same way that human inbreeding sometimes results in genetic disease and inferior health, some inbred plants also experience decreased fitness, and ...
Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications. In a report that will appear in Science and is receiving early online release, an international research team led by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard and from the Broad Institute of MIT and Harvard describe finding that differences in five amino acids in a protein called HLA-B are associated with whether or not HIV-infected ...
